The Readout Loud 285: CRISPR history, biotech struggles, & a big week for deals
Dec 7, 2023
Megan Molteni discusses the history and future of CRISPR-based medicine and the expected FDA approval of the first CRISPR-based medicine. Bruce Booth joins to discuss the challenges faced by the biotech industry and prospects for optimism in 2024.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Approval of CRISPR Gene Editing Medicine for Sickle Cell Disease
02:17 • 8min
The Impact of Chemotherapy on Fertility and Access to Fertility Preservation
09:56 • 6min
CRISPR-based Treatment for Sickle Cell Disease
16:00 • 6min
The State of the Biotech Industry
21:53 • 11min
Examining the Biotech Market and Anticipating Potential Growth in 2024
33:15 • 2min
Discussion on Atlas's performance and acquisitions in the obesity space
34:57 • 2min